Table 7 Bid-non-winning brands were used both before and after policy intervention

1

Fourth

Mosapride citrate tablets

Bid-non-winning

/

1.58

/

/

15.47

/

Bid-winning

2.29

2.27

-0.91%***

13.48

11.28

-16.34%

2

Fifth

Iodixanol injection

Bid-non-winning

546.23

543.50

-0.50%***

1.15

1.17

1.74%

Bid-winning

174.80

174.80

0.00%

2.00

1.25

-37.50%***

3

Fifth

Rivaroxaban tablets

Bid-non-winning

38.04

38.28

0.63%***

12.34

11.82

-4.21%***

Bid-winning

0.59

0.58

-1.37%

12.22

10.80

-11.64%

4

Fifth

Ropivacaine hydrochloride for injection

Bid-non-winning

68.55

68.55

0.00%

1.52

1.17

-23.09%

Bid-winning

59.46

13.76

-76.86% ***

1.13

1.13

-0.43%

5

Second

Hydrotalcite chewable tablets

Bid-non-winning

2.32

0.71

-69.33%

***

14.91

36.16

142.57%***

6

Second

Glimepiride tablets

Bid-non-winning

3.14

1.94

-38.18%

***

24.57

52.36

113.08%***

7

Second

Moxifloxacin hydrochloride tablets

Bid-non-winning

23.28

3.49

-84.99%

***

5.00

10.09

101.79%***

8

Second

Donepezil hydrochloride tablets

Bid-non-winning

38.23

5.73

-85.03%

***

16.33

30.01

83.74%***

9

Second

Paracetamol tablets

Bid-non-winning

0.56

0.53

-5.87%

***

22.34

21.48

-3.84%

10

Second

Tegafur gimeracil oteracil potassium capsule

Bid-non-winning

205.86

46.58

-77.37%

***

14.89

13.44

-9.75%***

11

Second

Amoxicillin capsule

Bid-non-winning

1.45

0.31

-78.42%

***

26.24

21.53

-17.97%***

12

Second

Simvastatin tablets

Bid-non-winning

2.95

2.30

-22.04%

***

20.32

14.83

-26.98%

13

Second

Candesartan cilexetil tablets

Bid-non-winning

1.43

0.45

-68.45%

***

41.72

19.79

-52.57%***

14

Third

Desloratadine tablets

Bid-non-winning

5.93

4.82

-18.81%

***

18.59

18.6

0.05%***

15

Third

Metformin hydrochloride sustained-release tablets

Bid-non-winning

2.26

2.26

0.00%

7.07

5.39

-23.76%

16

Third

Finasteride tablets

Bid-non-winning

5.57

4.10

-26.35%

***

27.58

20.02

-27.40%***

17

Fourth

Pregabalin capsule

Bid-non-winning

21.02

19.03

-9.47%

***

9.59

14.82

54.52%**

18

Fourth

Telmisartan tablets

Bid-non-winning

2.29

1.09

-52.43%

***

12.96

19.74

52.27%***

19

Fourth

Perindopril tert-butylamine tablets

Bid-non-winning

3.16

3.01

-4.88%

***

21.67

25.00

15.38%

20

Fourth

Gliclazide modified release tablets

Bid-non-winning

3.68

2.48

-32.73%

***

23.78

25.09

5.49%***

21

Fourth

Ambroxol hydrochloride injection

Bid-non-winning

12.01

0.95

-92.05%

***

16.90

17.44

3.18%***

22

Fourth

Repaglinide tablets

Bid-non-winning

2.62

2.40

-8.52%***

37.19

34.12

-8.25%

23

Fourth

Canagliflozin tablets

Bid-non-winning

3.79

3.78

-0.08%***

35.78

30.58

-14.53%

24

Fourth

Loratadine tablets

Bid-non-winning

2.91

2.91

-0.34%***

8.23

6.71

-18.57%***

25

Fourth

Ibuprofen injection

Bid-non-winning

148.80

30.87

-79.25%

***

1.60

1.22

-23.90%

26

Fourth

Esomeprazole magnesium enteric-coated tablets

Bid-non-winning

18.08

17.29

-4.33%***

11.83

8.12

-31.36%***

27

Fifth

Fluconazole and sodium chloride injection

Bid-non-winning

236.12

236.12

0.00%

9.92

19.00

91.54%

28

Fifth

Thioctic acid injection

Bid-non-winning

20.69

20.69

0.00%

44.31

52.39

18.23%***

29

Fifth

Fasudil hydrochloride injection

Bid-non-winning

91.75

91.75

0.00%

5.98

5.14

-13.97%**

30

Fifth

Levofloxacin and sodium chloride injection

Bid-non-winning

49.52

47.12

-4.85%***

6.83

5.27

-22.76%***

31

Fifth

Metoprolol tartrate tabets

Bid-non-winning

2.07

2.07

0.00%

4.76

3.47

-27.05%***